Risk of Transmission of Carbapenem-Resistant Enterobacteriaceae

Website http://bit.ly/1tgmRWj | Edit Freely

Category HealthCare; Quality Management Systems; Compliance training; Regulatory compliance training online;

Deadline: November 19, 2014 | Date: November 20, 2014

Venue/Country: Web Based-Seminar, U.S.A

Updated: 2014-10-29 15:25:04 (GMT+9)

Call For Papers - CFP

This lecture focuses on the recent emergence of the superbug carbapenem-resistant Enterobacteriaceae (CRE). The details of a recent outbreak of CRE following GI endoscopy performed at a hospital in Illinois in 2013, with associated morbidity and mortality, is discussed. Failure to properly clean and disinfect GI endoscopes and their accessories has been directly linked to superbug transmissions, increasing a GI endoscopy suite's legal exposure. The history of transmission of infectious pathogens before and since CRE's emergence in 2001 is discussed.

Re-accreditation by surveyors to ensure policies and procedures are thorough and intact requires an understanding about quality, risk management, and safe, evidence-based practices. Improved quality and safety are necessary to reduce costs and ensure the safety of patients. Focus is placed on the importance of strict adherence via confirmatory audits to ensure staffers' compliance with the GI endoscopy suite's policies and procedures, and guidelines, too. Attendees of this lecture will have a better understanding of superbugs, how to prevent their spread, and how to better reprocess GI endoscopes.

Areas Covered in the Session:

Infection control and disease prevention

Endoscope and instrument reprocessing

The principles of disease transmission

Quality assurance

Risk assessment and risk management

The physical design of GI endoscopes

Cleaning, disinfection, and sterilization

Infectious diseases

Who Will Benefit:

Nurse Managers

Endoscope Reprocessing staffers

Infection control practitioners

Risk Managers, Assessors

Hospital CEOs, Administrators

Quality Assurance Directors

Infection Disease Physicians

Speaker Profile:

Dr. Muscarella, is also the president of LFM Healthcare Solutions, LLC, a healthcare quality improvement company located near Philadelphia, PA. In 1990, Dr. Muscarella received his Ph.D. in bioengineering from the University of Pennsylvania. He contemporaneously completed a post-doctoral fellowship in diagnostic imaging at the Temple University School of Medicine. In 1983 he received a B.S. in physics from Ursinus College.

From 1991 through 1994, Dr. Muscarella worked as a project engineer for the ECRI Institute evaluating the quality and safety of medical devices and infection control products. From 1995 to 2013, Dr. Muscarella was the director of research and development for Custom Ultrasonics, Inc. In 1995, he founded the popular infection control newsletter, “The Q-Net Monthly,” which was published each month until 2013, when he founded this blog "Discussions in Infection Control,” the most replete infection control blog featuring more than 100 of his original articles. For almost two decades, Dr. Muscarella has researched and authored more than 150 articles on the topics of disinfection, sterilization, instrument reprocessing, risk management, infection control, modes of disease transmission, and factors that pose an increased risk of healthcare-acquired infections (HAIs), with a focus in the fields of gastrointestinal endoscopy and critical care.